RESEARCH-USE BIOSIMILAR ANTIBODY

Drozitumab

Monoclonal antibody · IgG1

TNFRSF10BIgG1RUO

Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma.

TARGETTNFRSF10B
YMonoclonal antibody
CATALOGSC-BS-612
CATALOG NUMBERSC-BS-612
MOLECULAR WEIGHTApprox. 143.06 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma.

Drozitumab is a recombinant research-use antibody directed against TNFRSF10B.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Drozitumab | StellaCyte